Improving Healthcare Access: GoApotik Participates in Health Screening for Bogor Residents

PT Medela Potentia Tbk, through GoApotik, participated in the free health screening program “Cek Segitiga” held in Bogor City. This initiative aims to raise public awareness about the importance of early detection of three chronic diseases: hypertension, diabetes, and high cholesterol.

A total of 490 Bogor residents took part in the screening, with the majority found to have elevated cholesterol levels, high blood pressure, and random blood sugar levels above the recommended thresholds. These findings clearly indicate that many individuals remain unaware of their current health conditions.

Approximately 72 percent of participants reported never having undergone a health check-up before, highlighting that the culture of early detection has yet to become a common practice—particularly among individuals in their productive age.

Mr. Krestijanto Pandji, President Director of PT Medela Potentia Tbk, emphasized the need to continuously improve access to healthcare services and products to enhance the overall quality of life in Indonesia.

"Our participation in the Cek Segitiga program reflects PT Medela Potentia Tbk’s long-term commitment to strengthening the national healthcare system through preventive action and the use of digital technology via GoApotik. Accessible healthcare products are essential in safeguarding the health of the Indonesian population," said Mr. Pandji.

As a digital health platform, GoApotik provides broader and easier access for the public to credible health information, licensed pharmaceutical products, and online consultation services that are simple to use.

Mrs. Ruth Retno Dewi, Director of PT Karsa Inti Tuju Askara (KITA), stated that GoApotik remains committed to delivering solutions that make it easier for people to meet their daily pharmaceutical and health needs.

"GoApotik enables users to conveniently access healthcare services. By simply downloading the app, users gain access to over 7,000 registered pharmacies and more than 50,000 health products," she explained.

PT KITA is a subsidiary of PT Medela Potentia Tbk that operates a digital health platform through the GoApotik application. GoApotik provides a comprehensive and reliable solution to meet the healthcare needs of the public.

Since the launch of the Cek Segitiga program in 2024, GoApotik has consistently participated in screenings across seven cities: Jakarta, Palembang, Bandung, South Tangerang, Surabaya, Yogyakarta, and most recently, Bogor. To date, over 5,000 individuals have benefited from this initiative.

The involvement of PT Medela Potentia Tbk through GoApotik in this program underscores its commitment to cross-sector collaboration in building a healthier, more health-aware society. By adopting a preventive, educational, and tech-based approach, Medela Potentia continues to provide impactful healthcare solutions for the people of Indonesia.